Cisplatin: from DNA damage to cancer chemotherapy. (Q34348474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Cisplatin: from DNA damage to cancer chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S J Lippard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

Progress in Molecular Biology and Translational Science

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

93-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Medicinal inorganic chemistry: introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Current status of platinum-based antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Platinum Compounds: a New Class of Potent Antitumour Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Testicular Germ-Cell Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Specific heavy metal labeling of the 3′-terminus of phosphorothioate modified yeast tRNAPhe

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Stereochemical requirements for intercalation of platinum complexes into double-stranded DNA's.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Recognition and reaction of metallointercalators with DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Binding of cis - and trans -Dichlorodiammineplatinum(II) to DNA: Evidence for Unwinding and Shortening of the Double Helix

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Inhibition of the BamHI cleavage and unwinding of pBR322 deoxyribonucleic acid by the antitumor drug cis-dichlorodiammineplatinum(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Spectrum of DNA-platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Inhibition of RNA Polymerase II Transcription in Human Cell Extracts by Cisplatin DNA Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

DNA Adducts of cis-Diamminedichloroplatinum(II) and Its Trans Isomer Inhibit RNA Polymerase II Differentially in Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

HMG domain proteins: architectural elements in the assembly of nucleoprotein structures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Isolation and characterization of cDNA clones encoding the Drosophila homolog of the HMG-box SSRP family that recognizes specific DNA structures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Structural features of the HMG chromosomal proteins and their genes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

TATA binding protein discriminates between different lesions on DNA, resulting in a transcription decrease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

The general transcription factors of RNA polymerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

DNA Sequence Context and Protein Composition Modulate HMG-Domain Protein Recognition of Cisplatin-Modified DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

HMG domain proteins induce sharp bends in cisplatin-modified DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

How proteins recognize the TATA box

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Characterization of high mobility group protein binding to cisplatin-damaged DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Structural and Kinetic Studies of a Cisplatin-modified DNA Icosamer Binding to HMG1 Domain B

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Solution structure of a DNA duplex containing a cis-diammineplatinum(II) 1,3-d(GTG) intrastrand cross-link, a major adduct in cells treated with the anticancer drug carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

The solution structure of a DNA duplex containing the cis-Pt(NH3)2[d(-GTG-)-N7(G),N7(G)] adduct, as determined with high-field NMR and molecular mechanics/dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Solution structure of a cisplatin-induced DNA interstrand cross-link

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Oxaliplatin (L-OHP): a new reality in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Molecular basis of human 46X,Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Structural basis for DNA bending by the architectural transcription factor LEF-1

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Structure and function of telomeres

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Telomeres do D-loop-T-loop

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Mammalian telomeres end in a large duplex loop

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

TRF2 Protects Human Telomeres from End-to-End Fusions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Creation of human tumour cells with defined genetic elements

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Preferential platination of an activated cellular promoter by cis-diamminedichloroplatinum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Inhibition of telomerase activity by cisplatin in human testicular cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Effect of the non-conserved N-terminus on the DNA binding activity of the yeast TATA binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Co-crystal structure of TBP recognizing the minor groove of a TATA element

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Crystal structure of a yeast TBP/TATA-box complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Enhanced binding of the TATA-binding protein to TATA boxes containing flanking cisplatin 1,2-cross-links

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Cisplatin adducts inhibit 1,N(6)-ethenoadenine repair by interacting with the human 3-methyladenine DNA glycosylase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Cell death: the significance of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Apoptosis: cell death in tissue regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Ubiquitin-dependent protein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II. Implications for transcription-coupled DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Cellular and molecular determinants of cisplatin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

DNA binding properties of [Pt(NH3)(C6H11NH2)Cl2], a metabolite of an orally active platinum anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Synthesis, characterization, and cytotoxicity of trifunctional dinuclear platinum complexes: comparison of effects of geometry and polyfunctionality on biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Beyond mere diversity: tailoring combinatorial libraries for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Comprehensive survey of combinatorial library synthesis: 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

A combinatorial approach to the discovery and optimization of luminescent materials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

A rare-earth phosphor containing one-dimensional chains identified through combinatorial methods

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Combinatorial libraries of transition-metal complexes, catalysts and materials

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

High-throughput synthesis and screening of platinum drug candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

1 reference

7 January 2021

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Metal complexes for therapy and diagnosis of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Synthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Mutagenic and carcinogenic properties of platinum-based anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicity and antitumor drug potential of platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Estrogen treatment induces elevated expression of HMG1 in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2967026-0

7 January 2021

10.1016/S0079-6603(01)67026-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525387%20AND%20SRC:MED&resulttype=core&format=json